The word from the manager: Mirabaud AM

'New top management could put Nestlé back on the path to growth'

"We expect the new management to concentrate activities on high-potential products and sell off underperforming divisions."

Daniele Scilingo, Responsabile Swiss Equities di Mirabaud Asset Management.

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

Daniele Scilingo, head of Swiss equities at Mirabaud Asset Management, outlines the European and US stock market scenario with a focus on the Swiss list.

Although growth has continued since the beginning of the year, do you think that European equity valuations continue to be attractive, both in absolute terms and compared to the US market?

European equities benefited from the interest of international investors driven by valuations and the search for diversification from the increasingly concentrated US market. For the rally to continue, concrete structural reforms are needed to sustain and accelerate growth in the medium and long term, supported by significant investment in infrastructure and innovation. Unfortunately, of Draghi's 380 proposals to create a more competitive Europe, only 10 per cent have been implemented. There is a need to speed things up.

Loading...

Do you think the ECB will remain on standby at the December meeting as well?

With the current uncertainties, central banks should wait for further developments on inflation developments that consider the full impact of tariffs. An unexpected cut could be caused by negative growth surprises.

IL TITOLO IN BORSA

Loading...

Between the European countries, how is the Swiss list doing? How much are US tariffs affecting the performance of companies and the country's growth?

Despite the turbulence in 2025, Swiss equities are fighting on a par with European equities, particularly in the segment of small- and mid-capitalisation companies. For most listed companies, the impact of tariffs is manageable, as many companies have a global production system. For purely Swiss products, such as watches, the consumer will pay the tariffs through higher prices. Many unlisted companies that have concentrated production in Switzerland to export to the world are suffering. Their strategy will have to be reviewed. With regard to GDP growth in the country, some economists estimate a negative impact of between 0.5% and 1%, which seems exaggerated considering the information we receive directly from companies.

And as far as currency is concerned, what do you expect?

More than tariffs, the weak dollar is causing Swiss companies a lot of discomfort. With the greenback down more than 10% since the beginning of the year, a Swiss company that generates on average 30% of its sales in dollars could lose 5-7 percentage points of sales growth and will have to manage significant pressure on margins. Historically, the franc appreciates by about 3% per year, putting pressure on companies to improve products and services and thus defend their market position and margins. Given the current situation, the franc will continue to appreciate, even if the Swiss central bank opts for negative interest rates.

I COMPARABLES

Loading...

In addition to tariffs, what other risks might weigh on you?

The weakness of the US dollar causes numerous problems for Swiss companies. Although in their DNA they can withstand headwinds, a collapse of the dollar cannot be compensated for in the short term.

So which areas should you focus on?

We are closely following stocks that have been overly penalised by this year's market trends. The medical technology sector as well as inherently defensive sectors such as food and pharma have suffered and could offer a nice opportunity.

IL CONFRONTO

Loading...

What approach to take when investing in this asset class?

In our selection, we look at high-quality stocks with strong growth potential and reasonable valuations. At the moment there are many sceptical investors who question the ability of many quality stocks to return to historical growth rates. Our decades of experience in the Swiss market allow us to assess the growth potential of individual stocks and take advantage of modest valuations.

Any particularly interesting titles?

Straumann. The company is a world leader in implant dentistry. For decades, it has been generating sales growth of around 10% with very high margins and a return on invested capital of 20%. In the last couple of quarters, the weak dollar and a slowdown in growth in the US have put the stock under heavy pressure. More recently published results, however, indicated accelerating growth in America and continued positive development in Europe. We also think Partners Group trades at modest levels despite being ideally positioned to benefit from growth in private markets. As a provider of innovative solutions, Partners Group will be able to participate in the strong demand for investments in private markets from private investors who currently have minimal exposure to this asset class. Several co-operations with Blackrock and Deutsche Bank open up a universe of private clients. Finally, we believe that a new chairman (Pablo Isla, former CEO of Inditex) and a new CEO could put Nestlé back on the path to growth and economic success. Growth in the third quarter could indicate the turning point for the multinational food company. We expect the new management team to act more aggressively to focus on products with high growth potential and to sell underperforming divisions.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti